Chamber and committees

I refer the member to the answer to question S6W-10433 on 20 September 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

As part of the Scottish Medicines Consortium’s (SMC) continuing role in the UK-wide multi-agency RAPID C-19 initiative, the collaborative partnership between the SMC and the National Institute for Health and Care Excellence (NICE) will extend to the multiple technology assessment (MTA) of the range of therapeutics for the treatment of COVID-19; therefore, a separate assessment of these medicines by the SMC will not be required.

I refer the member to the answer to question S6W-10385 on 20 September 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The consequentials form part of the savings package of over £500 million set out to the Finance and Public Administration Committee on September 7 th . As stated in the letter, savings have been utilised to meet increased costs as a result of inflationary pressures, increase help for those hit hardest by the cost of living crisis and to fund enhanced pay settlements.

The Lyme disease vaccine candidate VLA15 was developed in Austria and, as such, is not directly supported by Scottish funding. The Scottish Government is however regarded as preferred customers for Valneva, and should the decision be taken to procure Lyme Disease vaccines from Valneva, the Scottish Government will receive preferential access and pricing. This is in recognition of the support provided to Valneva by Scotland.

Scottish Enterprise have supported Valneva Livingston with funding packages for the following vaccines, all of which have received grant support:

• Japanese Encephalitis
• Zika
• Chikungya
• Covid-19

Non-NHS provider figures relate to patients treated in non-NHS locations such as private hospitals, hospices, nursing homes, and care homes. Patients who receive treatment at a private (independent) hospital which is paid for by the NHS board should be recorded within the SMR by the relevant NHS board.

The following table presents the procedure information that has been supplied to Public Health Scotland (PHS).

Table 1: The number of procedures performed by Non-NHS Providers.

I have a weekly portfolio meeting, usually held on a Monday, with officials and clinical advisers, including the Chief Medical Officer, during which any updates regarding the monkeypox outbreak in Scotland have been, and will continue to be, discussed.

As outlined in the answer to S6W-10089, the Cabinet Secretary for Health and Social Care attends regular meetings with his counterparts in the UK and other Devolved Administrations to ensure that the Scottish Government is represented in relation to public health incidents which require a coordinated 4 Nations response. The last meeting of the UK Health Ministers Forum was on 16 June 2022. The UK Health Ministers Forum has now been replaced by an Inter-Ministerial Group meeting which is expected to meet for the first time in mid-October.

The contract notice with Corporate Travel Management (North) Ltd, was published on 9 August 2022. The contract is to source and provide travel-related services for displaced people from Ukraine including accommodation in hotels and on the M/S Victoria I and M/S Ambition.

The full contract has a value of up to £100 million with a start date of 8 July 2022 and an end date of 12 December 2024. Both the M/S Victoria and the M/S Ambition have been initially chartered for a period of 6 months.

The Scottish Government provides funding to Advice Direct Scotland to deliver telephone and digital advice services including debt and consumer advice. Spend on external consultants is an operational matter and I direct the member to Advice Direct Scotland’s website or to their Chief Executive Officer for this information.

Throughout the pandemic, NHS Boards have ensured that urgent, maternity and vital cancer services continue as usual.

Any arrangements for NHS patients to be treated at an Independent Sector hospital would need to be made between the patient and the NHS Board prior to the treatment being carried out.